| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| (loss) gain on foreign currency hedges, net of cash | NaN | NaN | NaN | -65 |
| Net earnings | 17,197 | 19,736 | 13,690 | 31,891 |
| Depreciation and amortization | 8,810 | 8,658 | 8,835 | 17,045 |
| Non-cash inventory charges | NaN | 0 | NaN | NaN |
| Pension and other post-retirement plan expense | 72 | 25 | 26 | 117 |
| Stock-based compensation | 2,012 | 1,457 | 1,169 | 2,263 |
| Restructuring non-cash charges | NaN | 0 | NaN | NaN |
| Deferred income taxes | 772 | -1,083 | 755 | -84 |
| Change in fair value of contingent consideration liability | 53 | -998 | -1,054 | -1,523 |
| Loss on foreign currency hedges, net of cash | -31 | 524 | -204 | NaN |
| Goodwill prior period adjustment | NaN | 2,194 | NaN | NaN |
| Accounts receivable | 5,968 | 1,963 | 300 | 5,181 |
| Inventories | 4,692 | -1,485 | -2,853 | 2,960 |
| Operating lease assets | 7,184 | -1,071 | 1,904 | -1,230 |
| Other assets | -3,129 | 83 | 3,978 | -1,404 |
| Accounts payable | 2,757 | -654 | 1,820 | 3,017 |
| Accrued payroll and benefits | -6,126 | 1,562 | 1,472 | 354 |
| Operating lease liabilities | 7,167 | -1,135 | 1,872 | -1,282 |
| Accrued expenses and other liabilities | -735 | 3,873 | 3,670 | -2,402 |
| Pension and other post-retirement plans | 0 | -21 | -42 | -84 |
| Net cash provided by operating activities | 17,295 | 29,212 | 29,023 | 43,870 |
| Capital expenditures | 4,997 | 3,189 | 4,797 | 7,745 |
| Payments for acquisitions, net of cash acquired | NaN | 0 | 0 | NaN |
| Short-term investments | -2,888 | 2,783 | NaN | NaN |
| Net cash used in investing activities | -2,109 | -5,972 | -4,797 | -7,745 |
| Payments of long-term debt | 170,700 | 260,351 | 336,400 | 541,700 |
| Proceeds from borrowings of long-term debt | 175,700 | 227,151 | 339,100 | 537,400 |
| Purchases of treasury stock | 8,558 | 16,632 | 16,551 | 22,995 |
| Dividends paid | 1,151 | 1,167 | 1,182 | 2,401 |
| Contingent consideration payments | NaN | 0 | 0 | 0 |
| Taxes paid on behalf of equity award participants | 1,732 | 35 | 20 | 2,655 |
| Net cash used in financing activities | -6,441 | -51,034 | -15,053 | -32,351 |
| Effect of exchange rate changes on cash and cash equivalents | -189 | -207 | 1,683 | 1,332 |
| Net increase (decrease) in cash and cash equivalents | 8,556 | -28,001 | 10,856 | 5,106 |
| Cash and cash equivalents at beginning of period | 82,295 | 110,296 | 94,334 | NaN |
| Cash and cash equivalents at end of period | 90,851 | 82,295 | 110,296 | NaN |
CTS CORP (CTS)
CTS CORP (CTS)